Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

News & Events

: Tonix In The News

Home
News & Events
Tonix In The News

Tonix In The News

We need more than awareness to defeat the epidemic of veteran suicides

Washington Examiner |

September 23, 2019

Tonix Pharmaceuticals doses first patient in Phase 1 trial to treat PTSD

Proactive |

September 5, 2019

Military-related PTSD: Our year to act

Washington Examiner |

January 1, 2019

Scientists synthesize smallpox cousin in ominous breakthrough

Washington Post |

July 7, 2017

How Canadian researchers reconstituted an extinct poxvirus for $100,000 using mail-order DNA

Science |

July 6, 2017

Canadian synthesizes a better smallpox vaccine - just in case terrorists bring the disease back

The National Post |

March 2, 2017

Tonix Pharma PTSD drug shows promise in mid-stage study

Reuters |

May 19, 2016

UPDATE 2-Tonix Pharma PTSD drug shows promise in mid-stage study